A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

NCT04265261 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: Placebo
DRUG: RG7774

Sponsor

Hoffmann-La Roche